Noriko Sakasegawa

Acotiamide attenuates central urocortin 2‐induced intestinal inflammatory responses, and urocortin 2 treatment reduces TNF‐α productions in LPS‐stimulated macrophage cell lines

K. Iwakiri, S. Futagami, Y. Kodaka, 2020, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Management of functional dyspepsia: state of the art and emerging therapies

K. Iwakiri, S. Futagami, Y. Kodaka, 2018, Therapeutic advances in chronic disease.

Comparison of clinical symptoms, gastric motility and fat intake in the early chronic pancreatitis patients with anti-acid therapy-resistant functional dyspepsia patients

T. Akamizu, K. Iwakiri, S. Futagami, 2018, PloS one.

Camostat Mesilate, Pancrelipase, and Rabeprazole Combination Therapy Improves Epigastric Pain in Early Chronic Pancreatitis and Functional Dyspepsia with Pancreatic Enzyme Abnormalities

K. Iwakiri, S. Futagami, Y. Kodaka, 2018, Digestion.

Epigastric pain syndrome accompanying pancreatic enzyme abnormalities was overlapped with early chronic pancreatitis using endosonography

T. Akamizu, K. Iwakiri, S. Futagami, 2017, Journal of clinical biochemistry and nutrition.

New classification Rome IV functional dyspepsia and subtypes.

K. Iwakiri, S. Futagami, Y. Kodaka, 2018, Translational gastroenterology and hepatology.